India, Sept. 24 -- The United States Food and Drug Administration (USFDA) has issued a letter to doctors cautioning against routine use of acetaminophen (Tylenol) and other paracetamol products in pregnant women, citing studies that suggest possible links to autism and attention deficit hyperactivity disorder (ADHD).

"The FDA is taking action to make parents and doctors aware of a considerable body of evidence about potential risks associated with acetaminophen," USFDA Commissioner Marty Makary said in a statement on Tuesday.

The move follows controversial remarks by President Donald Trump and Health Secretary Robert Kennedy Jr, who claimed that Tylenol and similar products may raise the risk of autism.

Their comments coincided with th...